Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 2Leukemia 2Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Congenital Abnormalities 1

Interventions

Cytarabine 7Mitoxantrone 5fludarabine phosphate 3Peripheral Blood Stem Cell Transplantation 3Filgrastim 3Etoposide 3Cyclophosphamide 3Busulfan 3Vorinostat 2Tacrolimus 2Methotrexate 2Idarubicin 2Decitabine 2Bortezomib 2tanespimycin 1ixazomib 1fludarabine 1entinostat 1eltrombopag 1choline magnesium trisalicylate 1alvocidib 1Whole-Body Irradiation 1Thiotepa 1Sorafenib 1Proteasome Inhibitors 1Pravastatin 1Mycophenolic Acid 1Metformin 1Lenalidomide 1Immunologic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Megakaryoblastic, Acute × choline magnesium trisalicylate × Clear all
NCT00156299 2013-11-19

Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate

Rutgers, The State University of New Jersey

Phase 1 Terminated
15 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡